Cholera
Cholera is a disease, characterised by profuse, watery diarrhoea, caused by certain toxin-producing forms of the bacteria called Vibrio cholerae. Cholera is transmitted by ingesting (eating and drinking) contaminated water or food. It is common in many low-income countries and is largely linked to poverty, bad sanitation and poor access to clean drinking water.
The risk of cholera for most travellers is extremely low. Activities that may increase risk include drinking untreated water or eating poorly cooked food (particularly seafood) in areas where outbreaks are occurring. Travellers living in unsanitary conditions, including humanitarian workers in disaster/refugee areas, are also at risk.
Cholera can be mild or occur without symptoms in healthy individuals. Symptoms include sudden, profuse, watery diarrhoea with associated nausea and vomiting. If untreated, cholera can rapidly lead to serious dehydration and shock; fifty percent of those with serious complications, die. With quick and effective treatment, risk of dying is less than one percent.
Prevention
Travellers can reduce their risk of being ill from cholera by ensuring good personal hygiene and following advice on preventing food and water spread diseases.
Cholera vaccines
In the United Kingdom (UK) cholera vaccination is not recommended for most travellers. It is only advised for travellers whose activities or medical history put them at increased risk, including:
- Aid workers.
- Those going to areas of cholera outbreaks who have limited access to safe water and medical care.
- Those for whom vaccination is considered potentially beneficial (i.e. for those who do not fit into the above groups, but are still considered at higher risk).
There are two cholera vaccines available in the UK: Dukoral® and Vaxchora®.
Dukoral® is an oral (drink), inactivated cholera vaccine that protects against V. cholerae serogroup O1.
Vaccine schedule (Dukoral)
| Age range | Schedule | Duration of protection |
| Adults and children from 6 years | Two doses with an interval of at least 1 week but less than 6 weeks between them* | 2 years |
| Age 2 to below 6 years | Three doses with an interval of at least 1 week but less than 6 weeks between them* | 6 months |
*If more than 6 weeks have elapsed between doses the primary course should be restarted. If more than 2 years (or 6 months for children aged 2 to below 6 years of age) has elapsed since the last dose of vaccine, the primary course should be repeated.
Further information about Dukoral® can be found in the Summary of Product Characteristics (SPC).
Vaxchora® is also an oral (drink) cholera vaccine that protects against V. cholerae serogroup O1.
Vaxchora® is a live vaccine (it contains live attenuated cholera bacteria) and is contraindicated for anyone who is immunosuppressed. See the cholera chapter of Immunisation against infectious disease (also known as 'the Green Book'), for further details.
Vaccine schedule (Vaxchora)
| Age range | Schedule | Duration of protection |
| Adults and children from 2 years of age** | A single oral dose should be administered at least 10 days prior to potential exposure to V. cholerae O1 | No data are available on revaccination interval |
**The safety and efficacy of Vaxchora® in children less than 2 years has not been established.
Further information about Vaxchora® can be found in the Summary of Product Characteristics (SPC).
Resources
- More detailed information can be found in our cholera factsheet
- UKHSA: Immunisation against infectious disease. Cholera
- UKHSA: Guidance. The diagnosis, management and epidemiology of cholera
Explore more
Pertussis
Pertussis, also known as whooping cough is typically spread by the respiratory route when, for example, an infected person coughs or sneezes
Hepatitis A
Hepatitis A is an infection of the liver, and is transmitted through contaminated food and water or by direct contact with an infectious person
Chikungunya
Chikungunya is a viral infection caused by the chikungunya virus (CHIKV) and is transmitted through the bite of an infected mosquito
Altitude illness
Altitude illness describes a number of conditions that may occur in individuals ascending rapidly to high altitude, usually above 2,500m
Recent News on Cholera
Country Information updates: cholera
NaTHNaC has reviewed the country-specific cholera information and vaccine recommendations for United Kingdom (UK) travellers on the TravelHealthPro website
Updated: 20 November 2025Cholera cases reported in the United Kingdom and Germany linked to Ethiopia
Information for travellers and health professionals
Updated: 07 March 2025Updated cholera 'green book' chapter published
The cholera chapter in the 'green book' (Immunisation against infectious disease) has been updated
Updated: 01 August 2024Cholera vaccine shortage: advice for health professionals
Cholera cases increase worldwide, with shortages of cholera vaccine reported
Updated: 05 March 2024Recent Cholera Outbreaks
Cholera in Afghanistan
As of 10 November 2025, a total of 153,849 cholera cases, including 74 deaths have been reported in Afghanistan since 1 January 2025. Please see our Topics in Brief article for further details on cholera.
Cholera in Nepal
As of 17 November 2025, a total of 2,018 cholera cases have been reported in Nepal since 1 January 2025. In comparison, in 2024 up to 23 September 2024, a total of 95 cases were reported. Please see our Topics in Brief article for further details on cholera.
Cholera in Kenya
As of 17 November 2025, a total of 236 cholera cases, with six deaths, have been reported since the beginning of October 2025. Please see our Topics in Brief article for further details on cholera.
Cholera in South Sudan
As of 28 October 2025, a total of 94,549 cases of cholera including 1,567 deaths have been reported since the start of the outbreak. Nine out of ten states have been affected with the majority of cases reported in Rubkona, Juba, Mayom and Aweil West. Please see our Topics in Brief article for further details on cholera.
